HLA-E and neoplasm: Taking into account the confirmed unfavorable prognostic impact of this new inhibitory immune checkpoint NKG2A and its ligand HLA-E/β2m in terms of OS, our results provide additional arguments to consider that HLA-E/β2m overexpression by tumor cells promotes tumor progression in CRC and facilitates the metastatic dissemination through an immune escape mechanism.